Enhancing HIV Prevention with Injectable Preexposure Prophylaxis

Quarraisha Abdool Karim, Ph.D. writes about the results of HPTN 083 and the implications of long-acting injectable of PrEP with cabotegravir in the New England Journal of Medicine.

Population:
Cisgender Men
Gay and Bisexual Men Who Have Sex with Men
Transgender Women
Topics:
Tracking and Translating the Field